Keyword Suggestions

Results
 
 
Account Login
 
Username
 
 
 
Password
 
 
 
 
 

Library Navigation
 
 

Browse Conferences
 
 
 
18 Results Found, Showing 1 - 18
Sort By:
View:
Filter By:
Date/Time
Conference
Keyword
My Content
Start Date/Time:
End Date/Time:
 
Go
 
Conference
 
Keywords:
Click here to clear this filter
 
 
Go
Show only the content that I own
 
 
October 17, 2009 - Saturday
 
SA07 - mTor Pathways as a New Target in Endometrial and Ovarian Cancers 
Relevancy:
44.79% 
 
Date/Time:
October 17, 2009   1:00pm - 1:35pm
 
Length:
19m 47s - 26 Slides  
 
Total Credits:
0.50 CME  
 
Speaker:
Marcela Del Carmen, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA07 - mTor Pathways as a New Target in Endometrial and Ovarian Cancers 
Relevancy:
44.79% 
 
Date/Time:
October 17, 2009   1:00pm - 1:35pm
 
Length:
19m 47s - 26 Slides  
 
Speaker:
Marcela Del Carmen, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA08 - Using Targeted Agents (EGFR and VEGF Inhibitors) as Radiation Modifiers 
Relevancy:
59.83% 
 
Date/Time:
October 17, 2009   1:35pm - 2:10pm
 
Length:
26m 41s - 36 Slides  
 
Total Credits:
0.50 CME  
 
Speaker:
David B. Solit, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA08 - Using Targeted Agents (EGFR and VEGF Inhibitors) as Radiation Modifiers 
Relevancy:
59.83% 
 
Date/Time:
October 17, 2009   1:35pm - 2:10pm
 
Length:
26m 41s - 36 Slides  
 
Speaker:
David B. Solit, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA10 - How to Enroll Patients in Clinical Trials 
Relevancy:
52.95% 
 
Date/Time:
October 17, 2009   3:00pm - 3:35pm
 
Length:
37m 33s - 34 Slides  
 
Total Credits:
0.50 CME  
 
Speaker:
Deborah Collyar (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA10 - How to Enroll Patients in Clinical Trials 
Relevancy:
52.95% 
 
Date/Time:
October 17, 2009   3:00pm - 3:35pm
 
Length:
37m 33s - 34 Slides  
 
Speaker:
Deborah Collyar (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
September 24, 2009 - Thursday
 
rating
A101 - Introduction and Incidence and Mortality 
Relevancy:
50.24% 
 
Date/Time:
September 24, 2009   1:00pm - 1:25pm
 
Length:
19m 16s - 46 Slides  
 
Total Credits:
0.25 CME/CE  
 
Speaker:
Leonard S. Sender, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
U102 - The Risks and Benefits of Chemoprevention in Prostate Cancer 
Relevancy:
34.62% 
 
Date/Time:
September 24, 2009   1:35pm - 2:05pm
 
Length:
30m 16s - 37 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Andrew J. Stephenson, MD, FRCSC (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
ON102 - Compassion Fatigue: Implications for Oncology Nurses 
Relevancy:
29.92% 
 
Date/Time:
September 24, 2009   1:35pm - 2:05pm
 
Length:
27m 39s - 43 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
 
Format:
     
  Synched Audio / Slides
 

 
HM106 - JAK2 Mutations in MPD: A Worthy Therapeutic Target? 
Relevancy:
30.56% 
 
Date/Time:
September 24, 2009   4:05pm - 4:35pm
 
Length:
48m 47s - 46 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Olatoyosi Odenike, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
S102 - Moving Molecular Pathways to New Diagnostic Categories and New Therapeutic Strategies 
Relevancy:
73.87% 
 
Date/Time:
September 24, 2009   4:35pm - 5:05pm
 
Length:
24m 51s - 33 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
William Tap, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
HM108 - Therapy-Related Myeloid Neoplasms: The Price of Progress? 
Relevancy:
60.51% 
 
Date/Time:
September 24, 2009   5:10pm - 5:40pm
 
Length:
26m 24s - 50 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Wendy Stock, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
September 26, 2009 - Saturday
 
HM301 - CLL Treatment: Do Pre-treatment Characteristics Guide Current Treatment Choices? 
Relevancy:
28.33% 
 
Date/Time:
September 26, 2009   8:15am - 8:45am
 
Length:
22m 28s - 41 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Neil E. Kay, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
GI303 - Hepatocellular Carcinoma: New Trends and Contemporary Management 
Relevancy:
26.46% 
 
Date/Time:
September 26, 2009   9:25am - 9:55am
 
Length:
35m 09s - 59 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Andrew X. Zhu, MD, PhD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
HM303 - AML Therapy in the "Molecular Genetic" Era: How Does it Impact Therapeutic Approach? 
Relevancy:
100.00% 
 
Date/Time:
September 26, 2009   9:25am - 9:55am
 
Length:
40m 03s - 41 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Richard Stone, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
GI304 - Cytotoxic and Targeted Agents in Gastroesophageal Cancer 
Relevancy:
27.27% 
 
Date/Time:
September 26, 2009   1:30pm - 2:00pm
 
Length:
38m 40s - 62 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Manish P. Shah, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
HM305 - Debate: Is Allogenic Stem Cell Transplant in First Remission the Optimal Therapy for All Adults with ALL? 
Relevancy:
56.46% 
 
Date/Time:
September 26, 2009   2:05pm - 3:10pm
 
Length:
46m 53s - 78 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speakers:
Jerald P. Radich, MD (Speaker Disclosure)
 
Wendy Stock, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
L308 - Personalized Targeted Therapy in Lung Cancer 
Relevancy:
53.69% 
 
Date/Time:
September 26, 2009   4:40pm - 5:10pm
 
Length:
55m 05s - 55 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Waun Ki Hong, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
18 Results Found, Showing 1 - 18